AUS
NZ
UK
CA
USA
IND
Cannabis
Why This ASX Cannabis Story Is Drawing Fresh Attention
June 19, 2026 12:55 PM AEST| By SamASX cannabis stocks are facing greater scrutiny as patient access, prescription quality and regulatory discipline become central themes. Companies are increasingly evaluated on evidence, execution and sustainable operational performance.
Why Export Quality Is Reshaping ASX Cannabis Stocks
June 19, 2026 12:55 PM AEST| By Team Kalkine MediaAustralian cannabis companies are increasingly judged on export quality, compliance standards and commercial execution as European demand and operational discipline become key themes across the sector.
The Cannabis Metric Quietly Reshaping ASX 200 Watchlists
June 19, 2026 12:55 PM AEST| By SamASX cannabis stocks are increasingly being judged on cash runway, cost control and commercial scale as investors focus on financial resilience and sustainable business execution.
Tetratherix (ASX:TTX) Seeks Quotation of Shares as Escrow Period Ends
June 19, 2026 03:13 AM AEST| By Sonal GoyalFor anyone following the Tetratherix share price, understanding how escrow works and what this particular notice does and does not mean is useful context. This article explains exactly what was disclosed, why escrow expiries matter in the post-IPO life of a company, the broader …
Australia's Cannabis Market Is Booming - Can ASX Stocks Cash In?
June 18, 2026 04:00 PM AEST| By SamAustralia’s medicinal cannabis industry continues to expand through growing patient demand, telehealth adoption and broader treatment options, while regulatory hurdles, funding needs and international competition remain important challenges.
Vitura Health Drives ASX Cannabis Stock Consolidation Through Telehealth
June 18, 2026 03:45 PM AEST| By SamVitura Health is strengthening its position in Australia's medicinal cannabis sector through telehealth expansion, integrated healthcare services and strategic acquisitions, highlighting the growing consolidation trend shaping the industry's next sta...
Why Cash Runway Matters More Than Ever for ASX Cannabis Stocks
June 18, 2026 10:39 AM AEST| By SamAustralia's cannabis sector is evolving as investors place greater emphasis on cash runway, commercial execution and sustainable growth, shifting attention away from expansion narratives and towards long-term business performance.
What Are the Key Growth Drivers for Channel Infrastructure NZ (ASX:CHI)?
June 18, 2026 03:21 PM AEST| By Sonal GoyalChannel Infrastructure NZ (ASX:CHI) is an energy infrastructure business that stepped onto the Australian Securities Exchange on 19 December 2025, bringing a substantial fuel and energy infrastructure operation onto the radar of Australian investors. With a market capitalisation of around $1.06 billion, Channel Infrastructure …
Medicinal Cannabis Shares Meet A Stricter Export Check
June 18, 2026 10:39 AM AEST| By SamCannabis stocks face a sharper export quality test as medicinal access, product standards, revenue durability and funding discipline become central to the latest ASX sector story.
ASX 200 Cannabis Stocks Face A Revenue Test
June 18, 2026 10:39 AM AEST| By SamCannabis stocks remain under review as regulated access, medicinal demand, export revenue and capital discipline shape whether ASX operators can close the gap between sector interest and commercial scale.
ASX Cannabis Stocks: Why the Medicinal Access Filter Matters
June 17, 2026 03:04 PM AEST| By SamAustralia's medicinal cannabis sector is drawing renewed attention as markets focus on patient access, regulatory pathways and commercial execution. Companies with stronger revenue visibility, financial discipline and healthcare integration are becom...
ASX: DXB — Dimerix Lands Asian Licensing Deal Worth Up to $480m as Kidney Drug Story Expands
June 18, 2026 02:09 PM AEST| By Aditi SarkarHighlightsDimerix (ASX: DXB) has reported a regional licensing deal in Asia worth up to $480 million, expanding the commercial story around its kidney disease programme.Licensing deals of this kind typically involve upfront and milestone-based components, with the headline figure representing the maximum potential value …
ASX Cannabis Stocks: Cash Runway Reality Takes Centre Stage
June 17, 2026 02:54 PM AEST| By SamAustralian cannabis stocks are back in focus as investors assess cash runway, manufacturing scale, balance-sheet strength and operational execution. Companies with sustainable growth pathways are attracting the greatest market attention.
ASX 200 Cannabis Stocks Shift Toward Clinical Proof
June 17, 2026 11:07 AM AEST| By SamASX 200 cannabis stocks are increasingly shaped by clinical evidence as research-backed cannabinoid therapies support medical adoption, regulatory acceptance and global expansion across structured healthcare markets.
ASX Cannabis Stocks Face Reality Check in 2026
June 17, 2026 11:06 AM AEST| By SamASX cannabis stocks are entering a more mature phase where revenue, compliance and execution now define success, with Little Green Pharma and Cann Group reflecting the industry’s evolving commercial focus.
ASX: BOE — Boss Energy Stands Out as Uranium Demand Puts ASX Producers Back in Play
June 18, 2026 02:09 PM AEST| By Aditi SarkarHighlightsBoss Energy (ASX: BOE) is a uranium producer that has become a prominent name in the ASX uranium sector.Renewed uranium demand, underpinned by support for nuclear power, has put ASX uranium producers back in play.The Honeymoon project provides Boss Energy with production-stage exposure, discussed …
Cannabis Merger Shock Reshapes ASX Growth Story
June 17, 2026 11:06 AM AEST| By SamLittle Green Pharma’s merger with Cannatrek highlights growing consolidation in the Australian medicinal cannabis sector, with emphasis on manufacturing scale, regulated compliance and expanding European export opportunities.
ASX Cannabis Exports Drive Growth in Global Markets
June 17, 2026 04:21 AM AEST| By SamASX cannabis companies are expanding into Europe, with export-led growth reshaping sector structure and strengthening international supply chain integration.
Cash Runway Takes Centre Stage for ASX Cannabis Stocks
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are entering a more disciplined phase as investors focus on funding strength, operational execution and sustainable commercial growth.
ASX: EBR — EBR Systems Raises the Bar as Medtech Capital Markets Stay Tough
June 18, 2026 02:08 PM AEST| By Aditi SarkarHighlightsEBR Systems (ASX: EBR) is advancing wireless cardiac pacing technology within the implantable cardiac device sector.The company has moved to raise capital, underscoring the funding needs of commercial-stage medtech.The catalyst lands amid tough medtech capital markets, where funding access and terms are under scrutiny.Leadless, …
Export Standards or Scale? The New Challenge Facing Cannabis Stocks
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are increasingly being assessed on export readiness, operational execution and commercial scale as the medicinal cannabis sector continues to mature.
Regulatory Reality: Why Cannabis Stocks Are Back on Investors’ Watchlists
June 16, 2026 03:00 PM AEST| By SamASX cannabis stocks are being increasingly assessed through patient access, regulatory compliance, distribution strength and commercial execution as investors become more selective.
Little Green Pharma (ASX:LGP) Bulks Up as Cannatrek Merger Completes
June 16, 2026 11:35 AM AEST| By SamLittle Green Pharma completes its Cannatrek merger, strengthening vertical integration and scale as the ASX cannabis sector continues consolidating toward revenue-focused, regulated and operationally disciplined businesses.
Should You Keep Grandbridge (ASX:GBA) on Watchlists
June 18, 2026 12:07 PM AEST| By Sonal GoyalGrandbridge Limited (ASX:GBA) has become one of the more-discussed ASX small-caps in recent trading sessions, with rising trader attention turning the spotlight back onto this Australian investment and corporate advisory company. As a small-cap stock with exposure to a portfolio of unlisted and listed …
ASX Cannabis Stocks 2026: Revenue Now Leads Sector Shift
June 16, 2026 11:35 AM AEST| By SamASX cannabis stocks are entering a more disciplined phase where revenue, execution and regulatory compliance matter more than speculation, reshaping how investors view the sector.
Telix's New Healthcare Collaboration Sparks Fresh Market Discussion
June 16, 2026 10:43 AM AEST| By SamTelix Pharmaceuticals strengthened its precision medicine strategy through a new healthcare collaboration that combines imaging technologies, artificial intelligence tools, and theranostic workflows.
Advertise your brand on Kalkine Media